Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial

Overexpression of epidermal growth factor receptor can be found in more than 80% of patients with locoregionally advanced nasopharyngeal carcinoma and is associated with shorter survival. In this work, we evaluated the feasibility of adding nimotuzumab to chemoradiation in locoregionally advanced na...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jian-feng, Zhang, Fu-zheng, Zou, Qin-zhou, Zhou, Le-yuan, Yang, Bo, Chu, Jian-jun, Yu, Jia-hua, Zhang, Hao-wen, Yuan, Xiao-peng, Tai, Guo-mei, Liu, Fen-ju, Ma, C-M Charlie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356815/
https://www.ncbi.nlm.nih.gov/pubmed/27974693
http://dx.doi.org/10.18632/oncotarget.13899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356815/
https://www.ncbi.nlm.nih.gov/pubmed/27974693
http://dx.doi.org/10.18632/oncotarget.13899

Ejemplares similares